Drug profile · INN
freeze-dried polyethylene glycol-treated human normal immunoglobulin
KENKETU GLOVENIN-I PARTIAL CHANGE APPROVAL
freeze-dried polyethylene glycol-treated human normal immunoglobulin (KENKETU GLOVENIN-I PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.
Drug details — freeze-dried polyethylene glycol-treated human normal immunoglobulin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.78
Quick answer
freeze-dried polyethylene glycol-treated human normal immunoglobulin (KENKETU GLOVENIN-I PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Frequently asked questions
What is freeze-dried polyethylene glycol-treated human normal immunoglobulin?
freeze-dried polyethylene glycol-treated human normal immunoglobulin (KENKETU GLOVENIN-I PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for freeze-dried polyethylene glycol-treated human normal immunoglobulin?
KENKETU GLOVENIN-I PARTIAL CHANGE APPROVAL is a marketed brand name for freeze-dried polyethylene glycol-treated human normal immunoglobulin. Check FDA Drugs@FDA for the current US label holder and prescribing information.